[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.178.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
September 17, 2014

Guideline: New HCV Drugs Should Go to Sickest Patients

JAMA. 2014;312(11):1084-1085. doi:10.1001/jama.2014.11373

Patients who have advanced liver disease or other severe symptoms of hepatitis C virus (HCV) infection should be first in line for an expensive new medication for treating HCV, according to a new guideline. The guideline, from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America, was created with support from the International Antiviral Society–USA (IAS-USA). It is the latest in a series of guidelines from the groups on treating HCV.

First Page Preview View Large
First page PDF preview
First page PDF preview
×